CD262, Human (Lexatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD262, Human (Lexatumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD262, Human (Lexatumumab biosimilar)
CloneLexatumumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IP, FCM, FuncS, Neut, IF
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD262 Recombinant Antibody (Lexatumumab). Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015.
Immunogenn/a
Other NamesAnti-CD262 Recombinant Antibody, Research Grade Lexatumumab, Anti-Human CD262 Recombinant Antibody(Lexatumumab), HGS-ETR2, Antibody Drug Analogues, Monoclonal Antibody, YR1118, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 845816-02-6
Catalog #YR1118
Priceplease inquire
Order / More InfoCD262, Human (Lexatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.